ChemicalBook

ИНТЕРЛЕЙКИН 2

ИНТЕРЛЕЙКИН 2 структура
268535-76-8
CAS №
268535-76-8
Химическое название:
ИНТЕРЛЕЙКИН 2
английское имя:
INTERLEUKIN 2
Синонимы:
INTERLEUKIN 2;GenBank CAB65230;Interleukin 2 (turkey gene il2);GenBank CAB65230 (Translated from: GenBank AJ007463);Interleukin 2 (Meleagris gallopavo splenocyte gene il2);Interleukin 2 (Meleagris gallopavo gene IL-2 precursor)
CBNumber:
CB1636385
Формула:
молекулярный вес:
0
MOL File:
Mol file

ИНТЕРЛЕЙКИН 2 атрибут

температура хранения: -20°C
Справочник по базе данных CAS: 268535-76-8
Словарь онкологических терминов NCI: interleukin-2

Заявления о рисках и безопасности

ИНТЕРЛЕЙКИН 2 химические свойства, назначение, производство

Описание

Cetus has introduced a stable rDNA interleukin-2 (rIL-2) for the treatment of renal cell carcinoma. Recent studies showed that rIL-2 in combination with lymphokine activated killer cells or tumor infiltrating lymphocytes induced regression or partial regression in patients with advanced metastatic cancers.

Определение

A type of biological response modifier (a substance that can improve the body’s natural response to disease). It stimulates the growth of certain disease-fighting blood cells in the immune system. Also called IL-2.

Показания

IL-2 (Proleukin) is a cytokine that promotes the proliferation, differentiation, and recruitment of T and B lymphocytes, natural killer cells, and thymocytes. Human recombinant IL-2 is designated as rIL-2. rIL-2 binds to IL-2 receptors on responsive cells and induces proliferation and differentiation of T helper cells and T cytotoxic cells. It also can induce B-lymphocyte proliferation, activate macrophage activity, and augment the cytotoxicity of natural killer cells.

Механизм действия

rIL-2 is administered systemically as an immunostimulating agent in patients with AIDS and to augment specific antitumor immunity. Patients with renal cell carcinoma or melanoma have been effectively treated with rIL-2 in combination with adoptive transfer immunotherapy. The latter refers to the injection of the patient’s own cytokine-activated killer cells or tumorinfiltrating lymphocytes after they reside in tissue culture for several weeks in the presence of rIL-2.

Клиническое использование

Protein of rDNA origin that is used in treating renal cell carcinoma and metastatic malignant melanoma.

Побочные эффекты

Systemic administration of rIL-2 causes fever, nausea, vomiting, fatigue, and malaise. Other adverse affects include flushing, diarrhea, chills, rash, edema, symptomatic hypotension, and certain renal abnormalities. These tend to occur at increased dosage levels and are attenuated by reducing the dosage.

ИНТЕРЛЕЙКИН 2 препаратная продукция и сырье

сырьё

препарат


ИНТЕРЛЕЙКИН 2 поставщик

Global( 12)Suppliers
поставщик телефон страна номенклатура продукции благоприятные условия
Chengdu Youngshe Chemical Co., Ltd. +86-17380623303 +86-17380623303
China 4846 58
Sigma-Aldrich 021-61415566 800-8193336
China 51456 80
Copyright 2017 © ChemicalBook. All rights reserved